Status | Study |
Not yet recruiting |
Study Name: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy Condition: Acute Promyelocytic Leukemia Date: 2017-01-24 Interventions: Other: QoL questionnaires |
Recruiting |
Study Name: French Registry of First-line Treatment of Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-09-22 |
Recruiting |
Study Name: Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) Condition: Acute Promyelocytic Leukemia Date: 2016-09-04 Interventions: Drug: Realgar-Indigo naturalis formula |
Recruiting |
Study Name: Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-03-02 |
Recruiting |
Study Name: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-02-11 Interventions: Drug: Arsenic trioxide Other N |
Active, not recruiting |
Study Name: Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database Condition: Leukemia, Promyelocytic, Acute Date: 2014-12-03 |
Recruiting |
Study Name: Proteasome Inhibition in Acute Promyelocytic Leukemia Condition: Relapsed Acute Promyelocytic Leukemia Date: 2013-09-22 Interventions: Drug: Bortezomib Combination of arsenic trioxide with bortezomib in the treatment of relapsed acute prom |
Completed |
Study Name: Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2013-03-28 Interventions: Other: Health Related Quality of Life (HRQOL) measures Other Names: SF- |
Recruiting |
Study Name: Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL Condition: Acute Promyelocytic Leukemia Date: 2012-12-06 Interventions: Drug: ATRA+arsenic experimenta |
Active, not recruiting |
Study Name: Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy Condition: Acute Promyelocytic Leukemia Date: 2011-07-27 Interventions: Drug: Tretinoin and Arsenic Trioxide See Detailed Description |